Data Foundry

Drug recalls 2026

Lidocaine Ointment USP — Class II drug recall D-0848-2026

Ongoing recall by SUN PHARMA /TARO, reported 2026-09-23, distributed nationwide. Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long

Recall numberD-0848-2026
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmSUN PHARMA /TARO, Hawthorne, NY, United States
Recall initiated2026-08-31
Classified2026-09-15
Reported by FDA2026-09-23
DistributedNationwide (US)
Quantity65,328
Reason classespotency, specification failure
NDC51672-3008, 51672-3008-03, 51672-3008-05
Lot numbersAD48154
Expiration dates2027-04-30

Product

Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist By: Taro Pharmaceuticals U.S.A. Inc. Hawthorne NY 70532 NDC: 51672-3008-5

Reason for recall

Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0848-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-29. Not affiliated with or endorsed by FDA. Not medical or legal advice.